Anti-Zolpidem – (Clone ZOL-2314)
Anti-Zolpidem – (Clone ZOL-2314)
Product No.: Z102
- -
- -
Clone ZOL-2314 Formats AvailableView All Product Type Hybridoma Monoclonal Antibody Isotype Mouse IgG1 κ |
- -
- -
Antibody DetailsProduct DetailsHost Species Mouse Immunogen Zolpidem-BSA Product Concentration ≥1.0 mg/ml Purity >90% for SDS PAGE Formulation Formulated in 0.015M potassium phosphate buffered saline (0.85%), pH 7.2 and contains 0.05% sodium azide. State of Matter Liquid Product Preparation This monoclonal antibody is purified by ion exchange chromatography. Storage and Handling This purified antibody is stable when stored at 2-8°C. Do not freeze. Regulatory Status Research Use Only Country of Origin USA Shipping 2 – 8° C Wet Ice Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionSpecificity Anti-Zolpidem (clone ZOL-2314) has the following specificity:
Zolpidem Pheny-4-carboxylic Acid - 100%, Zolpidem - 80%, Zolpiclone - 0% Background Zolpidem is a widely prescribed medication for the short-term treatment of insomnia.
Introduced in the 1990s, zolpidem belongs to the class of sedative-hypnotic drugs
known as non-benzodiazepine receptor agonists, specifically acting on the
gamma-aminobutyric acid (GABA) type A receptors. By enhancing the inhibitory effects
of GABA, zolpidem induces a calming effect on the central nervous system, promoting
sleep initiation. While diagnostic testing for zolpidem is not common in routine clinical
practice, there is a high potential for overuse and dependence when using this drug.
Urine tests may be employed in cases of suspected misuse or overdose. The short
half-life of zolpidem necessitates timely testing to detect its presence accurately.
Clinicians may also consider diagnostic testing in situations where individuals exhibit
unusual reactions or experience adverse effects, ensuring proper management of
zolpidem use and promoting safe and effective treatment for insomnia. Antigen DetailsResearch Area Drug of Abuse . Matched Pair . IVD Raw Material References & CitationsBouchette D, Akhondi H, Quick J. Zolpidem. Treasure Island (FL): StatPearls Publishing;
2024 Jan. Link Text |
Formats Available
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
